What does concentric left ventricular (LV) remodeling on a 2D echocardiogram (2D echo) indicate in a patient with a history of hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Concentric Left Ventricular Remodeling on 2D Echocardiogram

Concentric LV remodeling represents an early adaptive response to chronic hypertension characterized by increased relative wall thickness (RWT ≥0.42) with normal left ventricular mass, indicating a late-stage maladaptive pattern that significantly increases cardiovascular risk even without frank hypertrophy. 1

Defining Characteristics

Concentric remodeling is diagnosed when:

  • RWT ≥0.42 (calculated as [2 × posterior wall thickness] / LV internal diameter at end-diastole) 2
  • Normal LV mass index (≤115 g/m² in men, ≤95 g/m² in women) 1, 2
  • Normal LV cavity size with proportionally thickened walls 1

This distinguishes it from concentric hypertrophy, which has both increased RWT AND increased LV mass. 1

Pathophysiology in Hypertension

The natural history follows a predictable sequence: 1

  • Early hypertension initially causes diastolic dysfunction without structural changes 1
  • Concentric remodeling develops as a late-stage response to chronic pressure overload 1
  • The ventricle becomes more spherical rather than bullet-shaped, fundamentally altering geometry 1
  • This represents offsetting effects where volume "underload" masks the pressure overload that would otherwise increase mass 3

Clinical Significance and Prognosis

Concentric remodeling carries substantial cardiovascular risk despite normal LV mass:

  • 2.56-fold increased risk of cardiovascular morbid events compared to normal geometry (95% CI 1.20-5.45, p<0.01) 4
  • Cardiovascular morbidity rate of 2.39 events per 100 patient-years versus 1.12 in normal geometry 4
  • This risk is independent of age, gender, diabetes, clinic blood pressure, and 24-hour ambulatory blood pressure 4

Associated Functional Consequences

The geometric changes produce dramatic functional impairment: 1

  • Severe diastolic dysfunction with impaired relaxation and elevated filling pressures 1
  • Loss of radial and longitudinal myocardial function 1
  • Increased peripheral vascular resistance with highest values seen in concentric patterns 3
  • Associated carotid intima-media thickening (0.68 vs 0.61 mm in normal geometry, p<0.05) 5

Hemodynamic Profile

Patients with concentric remodeling demonstrate: 3

  • Highest peripheral resistance among all geometric patterns
  • Low-normal cardiac index reflecting reduced cardiac output
  • Most elliptic cavity shape on short-axis imaging
  • Higher 24-hour ambulatory blood pressure readings (145/95 mmHg vs 134/87 mmHg, p<0.01) 5

Prevalence and Epidemiology

  • Occurs in 39.2% of hypertensive patients with normal LV mass 4
  • More common than classic concentric hypertrophy (13% vs 8% in untreated hypertensives) 3
  • Represents the most frequent geometric pattern after normal geometry in essential hypertension 3

Clinical Management Implications

This finding mandates aggressive intervention: 6, 7

  • Intensify blood pressure control with antihypertensive therapy 6
  • Implement comprehensive lifestyle modifications 6
  • Manage all cardiovascular comorbidities aggressively 6
  • LV remodeling is reversible with adequate blood pressure control 7
  • Serial echocardiographic monitoring to assess treatment response 1

Critical Pitfall to Avoid

Do not dismiss this finding as "normal" simply because LV mass is not elevated. The presence of increased RWT with normal mass indicates established hypertensive heart disease with proven adverse prognosis. 4 This pattern represents a late-stage adaptation that requires the same aggressive risk factor modification as frank LVH. 1, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosing Concentric Left Ventricular Hypertrophy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Left ventricular hypertrophy and hypertension.

Progress in cardiovascular diseases, 2020

Related Questions

Is concentric left ventricular (LV) remodeling the same as hypertrophy in a patient with a history of hypertension?
What is the primary treatment approach for a patient with concentric left ventricular (LV) remodeling and a history of hypertension?
What is the approach to left ventricular hypertrophy (LVH)?
What is the most appropriate initial antihypertensive medication for a patient with hypertension and left ventricular hypertrophy?
What is the primary risk factor for an elderly patient with ischemic heart disease (IHD), hypertension, and obesity, who is experiencing difficulty walking short distances and has mild left ventricular hypertrophy (LVH) on echocardiogram (echo)?
What to do with a vancomycin trough level of 23 mg/L in an adult or pediatric patient with a serious bacterial infection and potentially impaired renal function?
What is the management approach for a patient with low Complement (C) 3 and Complement (C) 4 levels, Autoimmune Hemolytic Anemia (AIHA), and myocarditis, suggesting an underlying systemic autoimmune condition such as Systemic Lupus Erythematosus (SLE)?
What is the appropriate treatment for a patient with a Trichophyton tonsurans infection?
What changes are recommended for Oral Hypoglycemic Agents (OHAs) in patients with diabetes during Ramadan fasting?
What is a normal eGFR score for a 63-year-old male with type 2 diabetes, single kidney, cholelithiasis, hepatic steatosis, and slightly enlarged spleen, with well-controlled hyperlipidemia and hypertension?
What is the recommended renal dose of meropenem for a patient with impaired renal function?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.